Found: 7
Select item for more details and to access through your institution.
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 11, p. 4765, doi. 10.1007/s00277-024-05924-4
- By:
- Publication type:
- Article
Dried blood spot sampling of nilotinib in patients with chronic myeloid leukaemia: a comparison with venous blood sampling.
- Published in:
- Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 10, p. 1265, doi. 10.1111/jphp.12757
- By:
- Publication type:
- Article
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effects.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1395, doi. 10.1007/s00277-023-05199-1
- By:
- Publication type:
- Article
Influence of WHO versus ELN advanced phase chronic myeloid leukemia definitions on overall survival.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 4, p. 381, doi. 10.1111/ejh.12928
- By:
- Publication type:
- Article
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study.
- Published in:
- Transfusion, 2019, v. 59, n. 1, p. 316, doi. 10.1111/trf.15037
- By:
- Publication type:
- Article
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 10, p. 679, doi. 10.1002/ajh.21489
- By:
- Publication type:
- Article